Skip to main content
. 2021 Dec 1;91(1):66–77. doi: 10.1002/ana.26268

TABLE 1.

Baseline Demographic Comparisons between SFN Main and Validation Cohorts

Characteristic Main Cohort Validation Cohort p
Mean (± SD) or n (% of total)
Total 58 33
Gender
M 31 (53.4%) 7 (21.2%) 0.016 a
F 27 (46.6%) 26 (78.8%)
Age, yr 50.0 (±13.6) 46.3 (±12.5) 0.209
Symptom description and signs
Positive 30 (51.7%) 25 (75.8%) 0.051
Negative 13 (22.4%) 2 (6.1%)
Both positive and negative 15 (25.9%) 6 (18.2%)
Topography based on symptoms
Length dependent 26 (44.8%) 21 (85.0%) 0.116
Non–length dependent 30 (51.7%) 12 (15.0%)
Not available 2 (3.45%) 0 (0%)
Autonomic symptoms b
No 14 (24.1%) 16 (48.5%) 0.103
Yes 32 (55.2%) 17 (51.5%)
Not available 12 (20.7%)
SFN diagnostic category
Possible 6 (10.3%) 1 (3.0%) 0.065
Probable 9 (15.5%) 2 (3.0%)
Definite 43 (74%) 31 (93.9%)
Etiology
Idiopathic 34 (58.6%) 18 (54.5%) 0.826
Secondary causes 24 (41.4%) 15 (45.5%)
a

Statistically significant.

b

Presence or absence of chronic diarrhea, constipation, urinary hesitancy or incontinence in the absence of other urological disorders, hyper‐/hypohidrosis, dry eyes/mouth/skin, chronic postural intolerance or orthostatic blood pressure drop, and chronic palpitations in the absence of cardiological disease.

F= female; M= male; SD= standard deviation; SFN= small fiber neuropathy.